Diabetes is a chronic condition that makes it difficult for your body to regulate blood sugar. When left unmanaged, both type 1 and type 2 diabetes can lead to serious health complications throughout ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

You may think diabetic macular edema (DME) affects older people only. But the truth is, the eye condition can develop in anyone with type 1 or type 2 diabetes. DME is more common in people with type 2 ...

Kodiak Sciences Inc. announced at the recent American Academy of Ophthalmology meetings that intraocular interleukin-6 inhibition in Phase 3 clinical trials delivered meaningful improvement in vision ...

The FDA has approved Lucentis (ranibizumab injection, from Genentech) for the treatment of macular edema following retinal vein occlusion (RVO). This approval was based on data from the BRAVO and ...

The MarketWatch News Department was not involved in the creation of this content. Vabysmo now covered across all three approved indications in the province, providing patients with a comprehensively ...

Branch retinal vein occlusion (BRVO) is when a blockage forms in the veins branching off the retina, which can disrupt blood flow. Treatment depends on the type of blockage and severity of the damage.

Treatment with high dose aflibercept 8 mg can lead to similar visual outcomes with fewer injections for patients with RVO.